Exact Sciences Corp. Reports Board and Executive Compensation Changes

Ticker: EXAS · Form: 8-K · Filed: Apr 29, 2025 · CIK: 1124140

Exact Sciences CORP 8-K Filing Summary
FieldDetail
CompanyExact Sciences CORP (EXAS)
Form Type8-K
Filed DateApr 29, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: governance, executive-compensation, board-changes

TL;DR

Exact Sciences board shakeup and exec pay changes filed today.

AI Summary

Exact Sciences Corp. announced on April 29, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory plans for key executives.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation matters, with no immediate financial implications disclosed.

Key Players & Entities

FAQ

What specific roles have seen departures of officers?

The filing indicates the departure of certain officers but does not specify the exact roles in this summary section.

When was the report filed?

The report was filed on April 29, 2025.

What is the principal business address of Exact Sciences Corp.?

The principal executive offices are located at 5505 Endeavor Lane, Madison, WI 53719.

What is the SIC code for Exact Sciences Corp.?

The Standard Industrial Classification (SIC) code is 8071, which corresponds to Medical Laboratories.

Are there any details on the new compensatory arrangements?

The filing mentions compensatory arrangements of certain officers but does not provide specific details within the provided text.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2025 regarding EXACT SCIENCES CORP (EXAS).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing